Literature DB >> 34460427

Serum Adsorption Study to Validate the Specificity of a Rapid Test to Detect Strongyloides stercoralis Infection.

Rahmah Noordin1, Emelia Osman2, Nor Suhada Anuar1, Nor Mustaiqazah Juri1, Anizah Rahumatullah1, Nur Athirah Ahmad Hilmi1.   

Abstract

A lateral flow rapid test for strongyloidiasis will greatly facilitate the control and elimination of the disease. Previously SsRapid prototype rapid test showed high diagnostic specificity to detect Strongyloides infection, determined using non-Strongyloides sera negative by IgG-ELISAs. Since high specificity is crucial before a test is used for public health control activities, further validation of its specificity is needed. Also, it needs to be ascertained whether non-Strongyloides sera positive by IgG-ELISAs and SsRapid are truly positive for Strongyloides or are cases of cross-reactivity. We performed 84 rapid tests (two types of dipsticks and cassettes) using 34 serum samples. They were divided into four groups based on Strongyloides infection and coinfection with other parasites and the availability of recombinant proteins and rapid tests for the latter. Sera was adsorbed using polystyrene microspheres beads separately coated with four recombinant parasite proteins. The small sample size is a limitation of this study; however, the overall results showed that the sera adsorption procedure was successful, and the SsRapid test is specific.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34460427      PMCID: PMC8592225          DOI: 10.4269/ajtmh.21-0674

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  1 in total

1.  Comparison of Two Serological Assays in Detecting Strongyloides Infection in Immunocompromised Patients.

Authors:  Emelia Osman; Nur Azma Amin; Thieeraporn Phraseart Ma Noon; Siti Nuratiqah Hanani Lahat; Mohamad Syairazi Rosli; Shazia Farhana Sham; Petrick Ramesh Periyasamy; Nuraffini Ghazali; Siti Nor Azreen Abd Manap; Rahmah Noordin
Journal:  Am J Trop Med Hyg       Date:  2022-07-25       Impact factor: 3.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.